Allovir Stock Target Price and Analyst Consensus

ALVR
 Stock
  

USD 7.62  0.23  3.11%   

The current analyst and expert consensus on Allovir is Buy, with 0 strong sell and 3 strong buy opinions. The current projected Allovir target price consensus is 42.75 with 4 analyst opinions. The most common way Allovir analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Allovir executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Allovir. We encourage you to use your own analysis of Allovir to validate this buy or sell advice. Allovir buy-or-sell recommendation module provides average expert sentiment on the projected Allovir target price to derive its highest and lowest estimates based on projected price volatility of 10.626. Please continue to Macroaxis Advice on Allovir to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Allovir Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Allovir target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Allovir target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions4
Lowered Outlook0
Raized Outlook0
Buy
Most Allovir analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Allovir stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Allovir, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Allovir Target Price Projection

Allovir's current and average target prices are 7.62 and 42.75, respectively. The current price of Allovir is the price at which Allovir is currently trading. On the other hand, Allovir's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Allovir Market Quote on 26th of September 2022

Low Price7.4Odds
High Price8.0Odds

7.62

Target Price

Analyst Consensus On Allovir Target Price

Low Estimate32.0Odds
High Estimate55.0Odds
Number of Analysts4
Standard Deviation10.626

42.75

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Allovir and the information provided on this page.

Allovir Analyst Ratings

Allovir's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Allovir stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Allovir's financials, market performance, and future outlook by experienced professionals. Allovir's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Allovir Target Price Projections

Allovir's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Allovir and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Allovir depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Allovir including analysis of its current option contracts.
Allovir's latest option contracts expiring on 2022-10-21 are carrying combined implied volatility of 135.23 with a put-to-call open interest ratio of 0.41 over 14 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2022-10-21. The current put volume is at 236, with calls trading at the volume of 63. This yields a 3.75 put-to-call volume ratio. The Allovir option chain provides detailed quote and price information for the current Allovir option contracts. It shows all of Allovir's listed puts, calls, expiration dates, strike prices, and other pricing information.
Allovir's stock options are financial instruments that give investors the right to buy or sell shares of Allovir common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Allovir stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Allovir's stock price goes up or down, the stock options follow.
Please continue to Macroaxis Advice on Allovir to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Allovir In The Money Call Balance

When Allovir's strike price is surpassing the current stock price, the option contract against Allovir stock is said to be in the money. When it comes to buying Allovir's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Allovir are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Allovir Current Options Market Mood

Allovir's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Allovir Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Allovir's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Allovir's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Allovir's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Allovir Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Allovir is a key component of Allovir valuation and have some predictive power on the future returns of a Allovir.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Allovir's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Allovir in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.387.6315.66
Details
Intrinsic
Valuation
LowReal ValueHigh
6.8616.2124.24
Details
Naive
Forecast
LowNext ValueHigh
0.167.9415.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.797.858.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Allovir. Your research has to be compared to or analyzed against Allovir's peers to derive any actionable benefits. When done correctly, Allovir's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Allovir.

Additional Allovir Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Allovir is a key component of Allovir valuation and have some predictive power on the future returns of a Allovir.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Allovir's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Allovir in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.387.6315.66
Details
Intrinsic
Valuation
LowReal ValueHigh
6.8616.2124.24
Details
Naive
Forecast
LowNext ValueHigh
0.167.9415.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.797.858.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Allovir. Your research has to be compared to or analyzed against Allovir's peers to derive any actionable benefits. When done correctly, Allovir's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Allovir.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested over 100 shares
Please continue to Macroaxis Advice on Allovir to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for analysis

When running Allovir price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
The data published in Allovir's official financial statements usually reflect Allovir's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Allovir. For example, before you start analyzing numbers published by Allovir accountants, it's critical to develop an understanding of what Allovir's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Allovir's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Allovir's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Allovir's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Allovir. Please utilize our Beneish M Score to check the likelihood of Allovir's management to manipulate its earnings.